Literature DB >> 8300592

Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes.

R A Lepley1, F A Fitzpatrick.   

Abstract

We report that leukotriene A4, the electrophilic product of 5-lipoxygenase catalysis, irreversibly inactivates the enzyme. Leukotriene A4 inhibits 5-hydroxyeicosatetraenoic acid formation by human neutrophils and differentiated granulocytic HL-60 cells in a concentration-dependent manner with IC50 values = 22.4 +/- 2.5 and 29.0 +/- 8.0 microM, respectively. Recovery of cellular enzymatic activity is negligible (< 6%) following inactivation. Leukotriene A4 inactivates cellular 5-lipoxygenase without inhibiting its translocation from the cytosol to the membrane, suggesting that it impairs catalysis without impairing formation of the complex between 5-lipoxygenase and its membrane-associated activating protein. Consistent with this, leukotriene A4 inactivates purified 5-lipoxygenase from human neutrophils, via saturable, pseudo first-order kinetics with a rate constant, ki = 0.14 min-1 and a dissociation constant, Ki = 2.1 +/- 0.7 microM. Purified 5-lipoxygenase incubated with [3H]arachidonic acid incorporated a radiolabeled species that was not removed by electrophoresis under reduced denaturing conditions. Preincubation with leukotriene A4 diminished the incorporation of radiolabeled material, consistent with irreversible modification of 5-lipoxygenase by its metastable product, leukotriene A4. This unusual product inactivation mechanism may contribute to the decline in 5-lipoxygenase activity observed during catalysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Authors:  R L Bell; R R Harris
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Regulated formation of eicosanoids.

Authors:  F A Fitzpatrick; R Soberman
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

3.  Identification of the Substrate Access Portal of 5-Lipoxygenase.

Authors:  Sunayana Mitra; Sue G Bartlett; Marcia E Newcomer
Journal:  Biochemistry       Date:  2015-10-08       Impact factor: 3.162

4.  Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages.

Authors:  T G Brock; R W McNish; M Peters-Golden
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach.

Authors:  Tatiana A Karelina; Kirill V Zhudenkov; Oleg O Demin; Dmitry V Svetlichny; Balaji Agoram; David Fairman; Oleg V Demin
Journal:  BMC Syst Biol       Date:  2012-11-12

Review 6.  Cell signalling by reactive lipid species: new concepts and molecular mechanisms.

Authors:  Ashlee Higdon; Anne R Diers; Joo Yeun Oh; Aimee Landar; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

7.  Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.

Authors:  Vikash Pandey; Marc Sultan; Karl Kashofer; Meryem Ralser; Vyacheslav Amstislavskiy; Julia Starmann; Ingrid Osprian; Christina Grimm; Hendrik Hache; Marie-Laure Yaspo; Holger Sültmann; Michael Trauner; Helmut Denk; Kurt Zatloukal; Hans Lehrach; Christoph Wierling
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 8.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.